-
1
-
-
79953192995
-
HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
-
Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8:222-32.
-
(2011)
Nat Rev Cardiol
, vol.8
, pp. 222-232
-
-
Navab, M.1
Reddy, S.T.2
Lenten, B.J.3
Fogelman, A.M.4
-
2
-
-
84893353712
-
Cardioprotective functions of HDLs
-
Rye KA, Barter PJ. Cardioprotective functions of HDLs. J Lipid Res. 2014;55:168-79.
-
(2014)
J Lipid Res
, vol.55
, pp. 168-179
-
-
Rye, K.A.1
Barter, P.J.2
-
3
-
-
77953852336
-
Anti-oxidant properties of high-density lipoprotein and atherosclerosis
-
Podrez EA. Anti-oxidant properties of high-density lipoprotein and atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37:719-25.
-
(2010)
Clin Exp Pharmacol Physiol
, vol.37
, pp. 719-725
-
-
Podrez, E.A.1
-
4
-
-
57349114776
-
HDL: bridging past and present with a look at the future
-
Scanu AM, Edelstein C. HDL: bridging past and present with a look at the future. FASEB J. 2008;22:4044-54.
-
(2008)
FASEB J
, vol.22
, pp. 4044-4054
-
-
Scanu, A.M.1
Edelstein, C.2
-
5
-
-
34249305527
-
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice
-
Ng CJ, Bourguard N, Hama SY, Shih D, Grijalva VR, Navab M, et al. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2007;27:1368-74.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 1368-1374
-
-
Ng, C.J.1
Bourguard, N.2
Hama, S.Y.3
Shih, D.4
Grijalva, V.R.5
Navab, M.6
-
6
-
-
66349083560
-
Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to anti-oxidative function
-
Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to anti-oxidative function. Arterioscler Thromb Vasc Biol. 2009;29:870-6.
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 870-876
-
-
Davidson, W.S.1
Silva, R.A.2
Chantepie, S.3
Lagor, W.R.4
Chapman, M.J.5
Kontush, A.6
-
7
-
-
77954215428
-
The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function
-
James RW, Deakin SP. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function. Adv Exp Med Biol. 2010;660:173-81.
-
(2010)
Adv Exp Med Biol
, vol.660
, pp. 173-181
-
-
James, R.W.1
Deakin, S.P.2
-
8
-
-
77955654901
-
The effect of HDL mimetic peptide 4F on PON1
-
Vakili L, Hama S, Kim JB, Tien D, Safarpoor S, Ly N, et al. The effect of HDL mimetic peptide 4F on PON1. Adv Exp Med Biol. 2010;660:167-72.
-
(2010)
Adv Exp Med Biol
, vol.660
, pp. 167-172
-
-
Vakili, L.1
Hama, S.2
Kim, J.B.3
Tien, D.4
Safarpoor, S.5
Ly, N.6
-
9
-
-
26844431924
-
Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation
-
Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, et al. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res. 2005;97:763-71.
-
(2005)
Circ Res
, vol.97
, pp. 763-771
-
-
Moore, R.E.1
Navab, M.2
Millar, J.S.3
Zimetti, F.4
Hama, S.5
Rothblat, G.H.6
-
10
-
-
79251573524
-
4F peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice
-
Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, et al. 4F peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2011;25:290-300.
-
(2011)
FASEB J
, vol.25
, pp. 290-300
-
-
Wool, G.D.1
Cabana, V.G.2
Lukens, J.3
Shaw, P.X.4
Binder, C.J.5
Witztum, J.L.6
-
11
-
-
84886502812
-
Therapeutic approaches to the regulation of metabolism of high-density lipoprotein. Novel HDL-directed pharmacological intervention and exercise
-
Zhang B, Kawachi E, Miura S, Uehara Y, Matsunaga A, Kuroki M, et al. Therapeutic approaches to the regulation of metabolism of high-density lipoprotein. Novel HDL-directed pharmacological intervention and exercise. Circ J. 2013;77:2651-63.
-
(2013)
Circ J
, vol.77
, pp. 2651-2663
-
-
Zhang, B.1
Kawachi, E.2
Miura, S.3
Uehara, Y.4
Matsunaga, A.5
Kuroki, M.6
-
12
-
-
84882336972
-
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical theraphy: part I
-
Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical theraphy: part I. Eur Heart J. 2013;34:2436-43.
-
(2013)
Eur Heart J
, vol.34
, pp. 2436-2443
-
-
Paneni, F.1
Beckman, J.A.2
Creager, M.A.3
Cosentino, F.4
-
13
-
-
84906846586
-
Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease
-
Lambadiari V, Kadoglou NP, Stasinos V, Maratou E, Antoniadis A, Kolokathis F, et al. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol. 2014;13:121.
-
(2014)
Cardiovasc Diabetol
, vol.13
, pp. 121
-
-
Lambadiari, V.1
Kadoglou, N.P.2
Stasinos, V.3
Maratou, E.4
Antoniadis, A.5
Kolokathis, F.6
-
14
-
-
84896699214
-
The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients
-
Li G, Lu WH, Ai R, Yang JH, Chen F, Tang ZZ. The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients. Cardiovasc Diabetol. 2014;13:52.
-
(2014)
Cardiovasc Diabetol
, vol.13
, pp. 52
-
-
Li, G.1
Lu, W.H.2
Ai, R.3
Yang, J.H.4
Chen, F.5
Tang, Z.Z.6
-
15
-
-
70349525016
-
Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes
-
Lu L, Pu LJ, Zhang Q, Wang LJ, Kang S, Zhang RY, et al. Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes. Atherosclerosis. 2009;206:540-5. 20.
-
(2009)
Atherosclerosis
, vol.206
, pp. 540-545
-
-
Lu, L.1
Pu, L.J.2
Zhang, Q.3
Wang, L.J.4
Kang, S.5
Zhang, R.Y.6
-
16
-
-
84871899931
-
Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study
-
Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi S, et al. Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study. Cardiovasc Diabetol. 2013;12:5.
-
(2013)
Cardiovasc Diabetol
, vol.12
, pp. 5
-
-
Fukushima, Y.1
Daida, H.2
Morimoto, T.3
Kasai, T.4
Miyauchi, K.5
Yamagishi, S.6
-
17
-
-
84887360982
-
Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion
-
Shen Y, Lu L, Ding FH, Sun Z, Zhang RY, Zhang Q, et al. Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Cardiovasc Diabetol. 2013;12:165.
-
(2013)
Cardiovasc Diabetol
, vol.12
, pp. 165
-
-
Shen, Y.1
Lu, L.2
Ding, F.H.3
Sun, Z.4
Zhang, R.Y.5
Zhang, Q.6
-
18
-
-
34447117721
-
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties
-
Hoang A, Murphy AJ, Coughlan MT, Thomas MC, Forbes JM, O'Brien R, et al. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia. 2007;50:1770-9.
-
(2007)
Diabetologia
, vol.50
, pp. 1770-1779
-
-
Hoang, A.1
Murphy, A.J.2
Coughlan, M.T.3
Thomas, M.C.4
Forbes, J.M.5
O'Brien, R.6
-
19
-
-
84876783625
-
Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients
-
Pu LJ, Lu L, Zhang RY, Du R, Shen Y, Zhang Q, et al. Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients. Diabetes Care. 2013;36:1312-20.
-
(2013)
Diabetes Care
, vol.36
, pp. 1312-1320
-
-
Pu, L.J.1
Lu, L.2
Zhang, R.Y.3
Du, R.4
Shen, Y.5
Zhang, Q.6
-
20
-
-
43049144209
-
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and non-enzymatic glycation of apolipoprotein A-I
-
Nobecourt E, Zeng J, Davies MJ, Brown BE, Yadav S, Barter PJ, et al. Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and non-enzymatic glycation of apolipoprotein A-I. Diabetologia. 2008;51:1008-17.
-
(2008)
Diabetologia
, vol.51
, pp. 1008-1017
-
-
Nobecourt, E.1
Zeng, J.2
Davies, M.J.3
Brown, B.E.4
Yadav, S.5
Barter, P.J.6
-
21
-
-
34249082855
-
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
-
Lebherz C, Sanmiguel J, Wilson JM, Rader DJ. Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent. CardiovascDiabetol. 2007;6:15.
-
(2007)
CardiovascDiabetol
, vol.6
, pp. 15
-
-
Lebherz, C.1
Sanmiguel, J.2
Wilson, J.M.3
Rader, D.J.4
-
22
-
-
58149153296
-
Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque
-
Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, et al. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res. 2008;103:1084-91.
-
(2008)
Circ Res
, vol.103
, pp. 1084-1091
-
-
Shaw, J.A.1
Bobik, A.2
Murphy, A.3
Kanellakis, P.4
Blombery, P.5
Mukhamedova, N.6
-
23
-
-
84855185039
-
Standards of medical care in diabetes-2012
-
American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35 Suppl 1:S11-63.
-
(2012)
Diabetes Care
, vol.35
, pp. S11-63
-
-
-
24
-
-
0347423198
-
Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, IZZO JL, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
IZZO, J.L.6
-
25
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39.
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
Brewer, H.B.4
Clark, L.T.5
Hunninghake, D.B.6
-
26
-
-
0030975078
-
A comparison of quantitative computerized and human panel coronary endpoint measures: Implications for the design of angiographic trials
-
Mark WJ, Azen SP, Dunn M, Hodis HN. A comparison of quantitative computerized and human panel coronary endpoint measures: Implications for the design of angiographic trials. Control Clin Trials. 1997;18:168-79.
-
(1997)
Control Clin Trials
, vol.18
, pp. 168-179
-
-
Mark, W.J.1
Azen, S.P.2
Dunn, M.3
Hodis, H.N.4
-
27
-
-
0346962893
-
Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity
-
Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol. 2004;93:159-64.
-
(2004)
Am J Cardiol.
, vol.93
, pp. 159-164
-
-
Solymoss, B.C.1
Bourassa, M.G.2
Campeau, L.3
Sniderman, A.4
Marcil, M.5
Lesperance, J.6
-
28
-
-
0034120965
-
Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells
-
Ren S, Shen GX. Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:1688-93.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1688-1693
-
-
Ren, S.1
Shen, G.X.2
-
29
-
-
58149384801
-
Paraoxonases (PON1, PON2, PON3) analysis in vitro and in vivo in relation to cardiovascular diseases
-
Aviram M, Rosenblat M. Paraoxonases (PON1, PON2, PON3) analysis in vitro and in vivo in relation to cardiovascular diseases. Methods MolBiol. 2008;477:259-76.
-
(2008)
Methods MolBiol
, vol.477
, pp. 259-276
-
-
Aviram, M.1
Rosenblat, M.2
-
30
-
-
78650913177
-
Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation
-
Weers PM, Patel AB, Wan LC, Guigard E, Kay CM, Hafiane A, et al. Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. J Lipid Res. 2011;52(1):35-44.
-
(2011)
J Lipid Res
, vol.52
, Issue.1
, pp. 35-44
-
-
Weers, P.M.1
Patel, A.B.2
Wan, L.C.3
Guigard, E.4
Kay, C.M.5
Hafiane, A.6
-
31
-
-
79960699072
-
Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state
-
Jang W, Jeoung NH, Cho KH. Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state. Mol Cells. 2011;31:461-70.
-
(2011)
Mol Cells
, vol.31
, pp. 461-470
-
-
Jang, W.1
Jeoung, N.H.2
Cho, K.H.3
-
32
-
-
84857491459
-
Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions
-
6375-86.35
-
Shao B, Pennathur S, Heinecke JW. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. J Biol Chem. 2012;287(9):6375-86.35.
-
(2012)
J Biol Chem
, vol.287
, Issue.9
-
-
Shao, B.1
Pennathur, S.2
Heinecke, J.W.3
-
33
-
-
84871018411
-
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
-
Murakami H, Tanabe J, Tamasawa N, Matsumura K, Yamashita M, Murakami H, et al. Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes. Diabetes Res Clin Pract. 2013;99:30-8.
-
(2013)
Diabetes Res Clin Pract
, vol.99
, pp. 30-38
-
-
Murakami, H.1
Tanabe, J.2
Tamasawa, N.3
Matsumura, K.4
Yamashita, M.5
Murakami, H.6
-
34
-
-
84930377712
-
Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes
-
(Study about 109 cases) Presse Med. 2015 Mar 10. doi:. [Epub ahead of print]
-
Fekih O, Triki S, Hellara J, Neffati F, Chouchane S, Neji Gueddiche M, Fadhel Naijar M. Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases) Presse Med. 2015 Mar 10. doi:10.1016/j.lpm.2014.10.020. [Epub ahead of print]
-
-
-
Fekih, O.1
Triki, S.2
Hellara, J.3
Neffati, F.4
Chouchane, S.5
Neji Gueddiche, M.6
Fadhel Naijar, M.7
|